부산대학교 도서관

Kataoka, K.; Stättner, S.; Shiozawa, M.; Mauer, M.; Kishi, Y.; Cabrieto, J.; Ducreux, M.; Suto, T.; Troisi, R.; Kang, H.C.; Nakamura, K.; Tonooka, T.; Rivoire, M.; Yasui, M.; Fung, A.; Caballero, C.; Matsuhashi, N.; Marreaud, S.; Kanemitsu, Y.; Evrard, S.

European Journal of Surgical Oncology. 51

Kataoka K; Division of Lower Gastrointestinal Surgery, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya Japan.; Mauer M; European Organisation For Research And Treatment Of Cancer Headquarters, Brussels, Belgium.; Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.; Marreaud S; European Organisation For Research And Treatment Of Cancer Headquarters, Brussels, Belgium.; Kishi Y; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.; Cabrieto J; European Organisation For Research And Treatment Of Cancer Headquarters, Brussels, Belgium.; Onaya H; Department of Diagnostic and Interventional Radiology, Aichi Cancer Center, Nagoya, Japan.; Ducreux M; Service d'Oncologie digestive, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Suto T; Department of Surgery, Yamagata Prefectural Hospital, Yamagata, Japan.; Kang HC; Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston.; Matsuhashi N; Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Hospital, Gifu, Japan.; Fung A; Oregon Health & Science University, Oregon Health & Science University, Portland.; Yasui M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.; Rivoire M; Department of Surgical Oncology, Centre Leon Berard, Lyon, France.; Tonooka T; Department of Esophago-Gastrointestinal Surgery, Chiba Cancer Center, Chiba, Japan.; Troisi RI; Department of Clinical Medicine and Surgery, Division of Hepatobiliary Surgery, Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University Hospital, Naples, Italy.; Nakamura K; Clinical Research Support Office, Research Management Division, National Cancer Center, Tokyo, Japan.; Stättner S; Department of Visceral, Transplantation and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria.; Kepler University Hospital GmbH, Department of General and Visceral Surgery, Medical Faculty, Johannes Kepler University, Linz, Austria.; Kinugasa Y; Department of Gastrointestinal Surgery, Hospital, Institute of Science Tokyo, Tokyo, Japan.; Foo WC; Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston.; Desolneux G; Digestive Tumors Unit, Institut Bergonie, Universite de Bordeaux, Bordeaux, France.; Bonhomme B; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Ikeda M; Division of Lower Gastrointestinal Surgery, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya Japan.; Caballero C; Breast International Group, Brussels, Belgium.; Lordick F; Department of Oncology, Gastroenterology, Hepatology and Pulmonology, University of Leipzig Medical Center, University Cancer Center, Leipzig, Germany.; Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.; Evrard S; Digestive Tumors Unit, Institut Bergonie, Universite de Bordeaux, Bordeaux, France.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101589553 Publication Model: Print Cited Medium: Internet ISSN: 2168-6262 (Electronic) Linking ISSN: 21686254 NLM ISO Abbreviation: JAMA Surg Subsets: MEDLINE

Eggermont A. M.; Meshcheryakov A.; Atkinson V.; Blank C. U.; Mandala M.; Long G. V.; Barrow C.; Di Giacomo A. M.; Fisher R.; Sandhu S.; Kudchadkar R.; Ortiz Romero P. L.; Svane I. M.; Larkin J.; Puig S.; Hersey P.; Quaglino P.; Queirolo P.; Stroyakovskiy D.; Bastholt L.; Mohr P.; Hernberg M.; Chiarion-Sileni V.; Strother M.; Hauschild A.; Yamazaki N.; van Akkooi A. C.; Lorigan P.; Krepler C.; Ibrahim N.; Marreaud S.; Kicinski M.; Suciu S.; Robert C.

Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Eggermont, A M M, Meshcheryakov, A, Atkinson, V, Blank, C U, Mandala, M, Long, G V, Barrow, C, Di Giacomo, A M, Fisher, R, Sandhu, S, Kudchadkar, R, Romero, P L O, Svane, I M, Larkin, J, Puig, S, Hersey, P, Quaglino, P, Queirolo, P, Stroyakovskiy, D, Bastholt, L, Mohr, P, Hernberg, M, Chiarion-Sileni, V, Strother, M, Hauschild, A, Yamazaki, N, van Akkooi, A C, Lorigan, P, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2021, ' Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma ', European Journal of Cancer, vol. 158, pp. 156-168 . https://doi.org/10.1016/j.ejca.2021.09.023
Eggermont, A MM, Meshcheryakov, A, Atkinson, V, Blank, C U, Mandala, M, Long, G V, Barrow, C, Di Giacomo, A M, Fisher, R, Sandhu, S, Kudchadkar, R, Ortiz Romero, P L, Svane, I M, Larkin, J, Puig, S, Hersey, P, Quaglino, P, Queirolo, P, Stroyakovskiy, D, Bastholt, L, Mohr, P, Hernberg, M, Chiarion-Sileni, V, Strother, M, Hauschild, A, Yamazaki, N, van Akkooi, A CJ, Lorigan, P, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2021, ' Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma ', European Journal of Cancer, vol. 158, pp. 156-168 . https://doi.org/10.1016/j.ejca.2021.09.023
Eggermont, A M, Meshcheryakov, A, Atkinson, V, Blank, C U, Mandala, M, Long, G V, Barrow, C, Di Giacomo, A M, Fisher, R, Sandhu, S, Kudchadkar, R, Ortiz Romero, P L, Svane, I M, Larkin, J, Puig, S, Hersey, P, Quaglino, P, Queirolo, P, Stroyakovskiy, D, Bastholt, L, Mohr, P, Hernberg, M, Chiarion-Sileni, V, Strother, M, Hauschild, A, Yamazaki, N, van Akkooi, A C, Lorigan, P, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2021, 'Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma', European journal of cancer (Oxford, England : 1990), vol. 158, pp. 156-168. https://doi.org/10.1016/j.ejca.2021.09.023

Bottomley A.; Coens C.; Mierzynska J.; Blank C. U.; Mandalà M.; Long G. V.; Atkinson V. G.; Dalle S.; Haydon A. M.; Meshcheryakov A.; Khattak A.; Carlino M. S.; Sandhu S.; Puig S.; Ascierto P. A.; Larkin J.; Lorigan P. C.; Rutkowski P.; Schadendorf D.; Koornstra R.; Hernandez-Aya L.; Di Giacomo A. M.; van den Eertwegh A. J. M.; Grob J. -J.; Gutzmer R.; Jamal R.; van Akkooi A. C. J.; Krepler C.; Ibrahim N.; Marreaud S.; Kicinski M.; Suciu S.; Robert C.; Eggermont A. M. M.; EORTC Melanoma Group; Lesimple T.; Maio M.; Linette G.; Mortier L.; Svane I. M.; Schachter J.; Brown M.; Hersey P.; Barrow C.; Kudchadkar R.; Dutriaux C.; Song X.; Quaglino P.; Queirolo P.; Meier F.; Stroyakovskiy D.; Guillot B.; Romero P. L. O.; Bastholt L.; Garbe C.; Grange F.; Mohr P.; Algazi A.; Bechter O.; Hernberg M.; Loquai C.; Meiss F.; Chiarion Sileni V.; Bar-Sela G.; Fitzharris B.; Saiag P.; Arnault J. -P.; Simon J. -C.; Stephens R.; Baurain J. -F.; Lebbe C.; Combemale P.; Dummer R.; Hauschild A.; Parente P.; Yamazaki N.; Milhem M.; Leccia M. -T.; Geoffrois L.; Kretschmer L.; Dunwoodie E.; Walker J.; Lotem M.; Hendler D.; Mackiewicz A.; Sekulovic L.; Dzienis M.; Hospers G. A. P.; Siano M.; Hassel J.; Corrie P.; Passos M. -J.; Levin M.; Hoeller C.; Machet L.; Hallmeyer S.; Waterston A.; Descamps V.; Kiecker F.; Aarts M.; Schmidt H.; Raimundo A.; Nyakas M.; Lacour J. -P.; Berking C.; Ferrucci P. F.; Jameson M.; Kim K.; Yokota K.; Kerger J.; Aubin F.; Groenewegen G.; Kapiteijn H.; Boehncke W. -H.; Utikal J.; Casasola R.; Marshall E.; Ferraresi V.; Richtig E.; Matkovic S.; Inozume T.; Crook T.; McNeil C.; Kiyohara Y.; Avril M. -F.; Hein R.; Terheyden P.; Nathan P.; Aoi J.; Skytta T.; Jouary T.; Takenouchi T.; Straume O.; Martins C.; Mukhametshina G.

EORTC Melanoma Group 2021, 'Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial', The Lancet Oncology, vol. 22, no. 5, pp. 655-664. https://doi.org/10.1016/S1470-2045(21)00081-4
Lancet Oncology, 22, 5, pp. 655-664
Lancet. Oncology, Vol. 22, No 5 (2021) pp. 655-664
EORTC Melanoma Group 2021, 'Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial', The Lancet Oncology, vol. 22, no. 5, pp. 655-664. https://doi.org/10.1016/S1470-2045(21)00081-4

Callegaro, D.; Raut, C.P.; Ajayi, T.; Strauss, D.; Bonvalot, S.; Ng, D.; Stoeckle, E.; Fairweather, M.; Rutkowski, P.; Houdt, W.J. van; Gelderblom, H.; Sangalli, C.; Hayes, A.; Honore, C.; Gladdy, R.A.; Fau, M.; Haas, R.; Tzanis, D.; Miah, A.B.; Chung, P.T.; Baldini, E.H.; Marreaud, S.; Litiere, S.; Swallow, C.J.; Gronchi, A.

Annals of Surgery. 278:127-134

Abdel-Rahman O; Medical Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Canada.; Taylor P; Medical Oncology, Wythenshawe Hospital, Manchester, United Kingdom.; O'Brien M; Lung Unit, The Royal Marsden Hospital NHS Foundation Trust & Institute of Cancer Research, London and Surrey, United Kingdom.; Raskin J; Thoracic Oncology, UZA - University Hospital Antwerp, Edegem, Belgium.; Dazzi C; Medical Oncology, Ospedale Santa Maria delle Croci, Ravenna, Italy.; Surmont V; Respiratory Medicine/thoracic oncology, UZ Gent - Universitair Ziekenhuis Gent, Gent, Belgium.; Zonato S; Azienda Sociosanitaria Territoriale Santi Paolo E Carlo, Italy.; Young R; Weston Park Cancer Centre- Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Toffart AC; Pulmonology unit, CHU Grenoble-Alpes - Le site nord à La Tronche - Hopital Michallon, La Tronche, France.; Jankowska P; Oncology, Musgrove Park Hospital - Somerset NHS Foundation Trust, Taunton, United Kingdom.; Hassani A; Oncology, South Tyneside District Hospital, South Tyneside and Sunderland NHS Foundation Trust, South Shields, United Kingdom.; Marreaud S; Medical Department, EORTC AISBL/IVZW - European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Boone L; Medical Department, EORTC AISBL/IVZW - European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Popat S; Lung Unit, The Royal Marsden Hospital NHS Foundation Trust & Institute of Cancer Research, London and Surrey, United Kingdom. Electronic address: sanjay.popat@rmh.nhs.uk.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Casali P. G.; Le Cesne A.; Velasco A. P.; Kotasek D.; Rutkowski P.; Hohenberger P.; Fumagalli E.; Judson I. R.; Italiano A.; Gelderblom H.; Penel N.; Hartmann J. T.; Duffaud F.; Goldstein D.; Martin-Broto J.; Gronchi A.; Wardelmann E.; Marreaud S.; Zalcberg J. R.; Litiere S.; Blay J. -Y.

RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
instname

Alexander M. M. Eggermont; Christian U. Blank; Mario Mandala; Georgina V. Long; Victoria G. Atkinson; Stéphane Dalle; Andrew M. Haydon; Andrey Meshcheryakov; Adnan Khattak; Matteo S. Carlino; Shahneen Sandhu; James Larkin; Susana Puig; Paolo A. Ascierto; Piotr Rutkowski; Dirk Schadendorf; Rutger Koornstra; Leonel Hernandez-Aya; Anna Maria Di Giacomo; Alfonsus J. M. van den Eertwegh; Jean-Jacques Grob; Ralf Gutzmer; Rahima Jamal; Paul C. Lorigan; Alexander C. J. van Akkooi; Clemens Krepler; Nageatte Ibrahim; Sandrine Marreaud; Michal Kicinski; Stefan Suciu; Caroline Robert

Journal of Clinical Oncology, 39, 8, pp. 944-946

Alexander M.M. Eggermont; Christian U. Blank; Mario Mandala; Georgina V. Long; Victoria G. Atkinson; Stéphane Dalle; Andrew Haydon; Mikhail Lichinitser; Adnan Khattak; Matteo S. Carlino; Shahneen Sandhu; James Larkin; Susana Puig; Paolo A. Ascierto; Piotr Rutkowski; Dirk Schadendorf; Rutger Koornstra; Leonel Hernandez-Aya; Anna Maria Di Giacomo; Alfonsus JM. van den Eertwegh; Jean-Jacques Grob; Ralf Gutzmer; Rahima Jamal; Paul C. Lorigan; Robert Lupinacci; Clemens Krepler; Nageatte Ibrahim; Michal Kicinski; Sandrine Marreaud; Alexander C. van Akkooi; Stefan Suciu; Caroline Robert

Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Lupinacci, R, Krepler, C, Ibrahim, N, Kicinski, M, Marreaud, S, van Akkooi, A C, Suciu, S & Robert, C 2019, 'Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma', European Journal of Cancer, vol. 116, pp. 148-157. https://doi.org/10.1016/j.ejca.2019.05.020
European Journal of Cancer, 116, pp. 148-157
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A JM, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, Lupinacci, R, Krepler, C, Ibrahim, N, Kicinski, M, Marreaud, S, van Akkooi, A C, Suciu, S & Robert, C 2019, 'Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma', European Journal of Cancer, vol. 116, pp. 148-157. https://doi.org/10.1016/j.ejca.2019.05.020

Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson V; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto P; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Maio M; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan P; Ibrahim N; Marreaud S; van Akkooi ACJ; Suciu S; Robert C

Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Articles publicats en revistes (Medicina)
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Maio, M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P, Ibrahim, N, Marreaud, S, van Akkooi, A C J, Suciu, S & Robert, C 2018, 'Adjuvant pembrolizumab versus placebo in resected stage III melanoma', New England Journal of Medicine, vol. 378, no. 19, pp. 1789-1801. https://doi.org/10.1056/NEJMoa1802357
The New England Journal of Medicine, 378, 19, pp. 1789-1801
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Maio, M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P, Ibrahim, N, Marreaud, S, van Akkooi, A C J, Suciu, S & Robert, C 2018, 'Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma', The New England Journal of Medicine, vol. 378, no. 19, 10.1056/NEJMoa1802357, pp. 1789-1801. https://doi.org/10.1056/NEJMoa1802357

Stacchiotti S; Department of Medical Oncology, Adult Mesenchymal and Rare Tumours Unit Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.; Pantziarka P; Anticancer Fund, Meise, Belgium; George Pantziarka TP53 Trust, London, United Kingdom.; Leonard H; The EHE Rare Cancer Charity, Kingston-Upon-Thames, United Kingdom.; Voltz C; European Medicines Agency, Amsterdam, The Netherlands.; Abatedaga L; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; TU.TO.R. Tumori Toracici Rari, Patient Advocacy, Milan, Italy.; Bouche G; Anticancer Fund, Meise, Belgium.; Bouygues C; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Bovee JVMG; Department of Pathology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.; Van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Rojas T; Arztpraxis Mylife Fulenbach, Fulenbach, Switzerland.; D'Ambrosio L; Department of Medical Oncology, University of Turin, Turin, Italy.; Donoghue M; U.S. Food and Drug Administration, Silver Spring, MD, United States.; Enzmann H; European Medicines Agency, Amsterdam, The Netherlands.; Feeney G; Sarcoma Patient Advocacy Global Network, Wolfersheim, Germany.; Foggi P; Agenzia Italiana del Farmaco, Rome, Italy.; Frezza AM; Department of Medical Oncology, Adult Mesenchymal and Rare Tumours Unit Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Herold R; European Medicines Agency, Amsterdam, The Netherlands.; Jones RL; Sarcoma Unit, The Royal Marsden NHS and Institute of Cancer Research, London, United Kingdom.; Kasper B; Sarcoma Unit, Mannheim Cancer Center, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.; Roes K; Radboud University Medical Center, Department IQ Health, Biostatistics, Nijmegen, The Netherlands.; Marreaud S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Miceli R; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Robinson D; The EHE Foundation, Hobart, WI, United States.; Sommer J; The Chordoma Foundation, Durham, NC, United States.; Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.; Tydings C; Sarcoma Patient Advocacy Global Network, Wolfersheim, Germany.; Trama A; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Houdt WV; Netherland Cancer Institute, Amsterdam, The Netherlands.; van Oortmerssen G; Sarcoma Patient Advocacy Global Network, Wolfersheim, Germany.; Wagner AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Widemann B; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Gelderblom H; Department of Medical Oncology , Leiden University Medical Center, Leiden, The Netherlands.; Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Napolitano A; Sarcoma Unit, The Royal Marsden NHS and Institute of Cancer Research, London, United Kingdom.; Dufresne A; Department of Medical Oncology, Centre Leon Berard, Lyon, France.; Fumagalli ER; Department of Medical Oncology, Adult Mesenchymal and Rare Tumours Unit Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Baldi G; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.; Marquina G; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain.; Koseła-Paterczyk H; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Martin Javier JB; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain.; Junker N; Department of Oncology, Sarcoma Unit, Herlev and Gentofte Hospital, Copenhagen, Denmark.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Oyen WJG; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Lacombe D; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Pignatti F; European Medicines Agency, Amsterdam, The Netherlands.; Demolis P; Icelandic Medicines Agency, Iceland.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Touati, N. ; Schöffski, P. ; Litière, S. ; Judson, I. ; Sleijfer, S. ; van der Graaf, W.T. ; Italiano, A. ; Isambert, N. ; Gil, T. ; Blay, J.Y. ; Stark, D. ; Brodowicz, T. ; Marréaud, S. ; Gronchi, A.

In Clinical Oncology July 2018 30(7):448-454

Verschoor, A.J. ; Litière, S. ; Marréaud, S. ; Judson, I. ; Toulmonde, M. ; Wardelmann, E. ; van der Graaf, W.T. ; Le Cesne, A. ; Gronchi, A. ; Gelderblom, H.

In European Journal of Cancer May 2018 94:187-198

Stadler R; University Clinic for Dermatology, Ruhr University of Bochum, Minden, Germany. Electronic address: rudolf.stadler@ruhr-uni-bochum.de.; Roccuzzo G; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Electronic address: gabriele.roccuzzo@unito.it.; Ortiz-Romero P; Department of Dermatology, Hospital Universitario 12 de Octubre, Institute i+ 12, University Complutense, Madrid, Spain.; Bagot M; Department of Dermatology, Hôpital Saint-Louis, Université Paris Cité, Paris, France.; Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.; Guenova E; Department of Dermatology, Lausanne University Hospital (CHUV) and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; University Institute and Clinic for Immunodermatology, Medical Faculty, Johannes Kepler University, Linz, Austria.; Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Papadavid E; Second Department of Dermatology, National and Kapodistrian University of Athens, Athens, Greece.; Stranzenbach R; Department of Dermatology, St. Josef Hospital, UK RUB, Bochum, Germany.; Marreaud S; EORTC Headquarters, Brussels, Belgium.; Musoro J; EORTC Headquarters, Brussels, Belgium.; Casas-Martin J; EORTC Headquarters, Brussels, Belgium.; Murray D; Department of Haematology, University Hospitals Coventry and Warwickshire and Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom.; Drennan S; Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, United Kingdom.; Hear JV; Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, United Kingdom.; Moss P; Department of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, United Kingdom.; Sartori D; EORTC Headquarters, Brussels, Belgium.; Battistella M; Department of Pathology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Inserm U976, Paris, France.; Willemze R; Department of Dermatology, Leiden University Medical Center, the Netherlands.; Scarisbrick J; Department of Dermatology, University Hospital Birmingham, Birmingham, United Kingdom.; Knobler R; Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Schöffski, P. ; Wozniak, A. ; Kasper, B. ; Aamdal, S. ; Leahy, M.G. ; Rutkowski, P. ; Bauer, S. ; Gelderblom, H. ; Italiano, A. ; Lindner, L.H. ; Hennig, I. ; Strauss, S. ; Zakotnik, B. ; Anthoney, A. ; Albiges, L. ; Blay, J.-Y. ; Reichardt, P. ; Sufliarsky, J. ; van der Graaf, W.T.A. ; Debiec-Rychter, M. ; Sciot, R. ; Van Cann, T. ; Marréaud, S. ; Raveloarivahy, T. ; Collette, S. ; Stacchiotti, S.

In Annals of Oncology March 2018 29(3):758-765

Younger, E; Litière, S; Le Cesne, A; Mir, O; Gelderblom, H; Italiano, A; Marreaud, S; Jones, RL; Gronchi, A; van der Graaf, WTA

Oncologist, 23, 10, pp. 1250-1259
Oncologist

Schöffski, P. ; Wozniak, A. ; Stacchiotti, S. ; Rutkowski, P. ; Blay, J.-Y. ; Lindner, L.H. ; Strauss, S.J. ; Anthoney, A. ; Duffaud, F. ; Richter, S. ; Grünwald, V. ; Leahy, M.G. ; Reichardt, P. ; Sufliarsky, J. ; van der Graaf, W.T. ; Sciot, R. ; Debiec-Rychter, M. ; van Cann, T. ; Marréaud, S. ; Lia, M. ; Raveloarivahy, T. ; Collette, L. ; Bauer, S.

In Annals of Oncology December 2017 28(12):3000-3008

O'Brien, M.; Paz-Ares, L.; Marreaud, S.; Dafni, U.; Oselin, K.; Havel, L.; Esteban, E.; Isla, D.; Martinez-Marti, A.; Faehling, M.; Tsuboi, M.; Lee, J.-S.; Nakagawa, K.; Yang, J.; Samkari, A.; Keller, S.M.; Mauer, M.; Jha, N.; Stahel, R.; Besse, B.; Peters, S.; EORTC-1416-LCG/ETOP 8-15 - PEARLS/KEYNOTE-091 Investigators

Grégoire, V.; Tao, Y.; Kaanders, J.; Machiels, J.; Vulquin, N.; Nuyts, S.; Fortpied, C.; Lmalem, H.; Marreaud, S.; Overgaard, J.

Radiotherapy and Oncology. 161:S187-S188

Gelderblom, H. ; Blay, J.Y. ; Seddon, B.M. ; Leahy, M. ; Ray-Coquard, I. ; Sleijfer, S. ; Kerst, J.M. ; Rutkowski, P. ; Bauer, S. ; Ouali, M. ; Marreaud, S. ; van der Straaten, R.J.H.M. ; Guchelaar, H.-J. ; Weitman, S.D. ; Hogendoorn, P.C.W. ; Hohenberger, P.

In European Journal of Cancer January 2014 50(2):388-396